These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24668273)

  • 1. Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.
    Tan CP; Lu YY; Ji LN; Mao ZW
    Metallomics; 2014 May; 6(5):978-95. PubMed ID: 24668273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic agents triggering nonapoptotic cancer cell death.
    Kornienko A; Mathieu V; Rastogi SK; Lefranc F; Kiss R
    J Med Chem; 2013 Jun; 56(12):4823-39. PubMed ID: 23517069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and cell death pathways invoked by two new rhodium-ferrocene complexes in benign and malignant prostatic cell lines.
    Weber B; Serafin A; Michie J; Van Rensburg C; Swarts JC; Bohm L
    Anticancer Res; 2004; 24(2B):763-70. PubMed ID: 15161024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Signal pathways of cell proliferation and death as targets of potential chemotherapeutics].
    Repický A; Jantová S; Milata V
    Ceska Slov Farm; 2008 Jan; 57(1):4-10. PubMed ID: 18383917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed cell death and cancer.
    Sun Y; Peng ZL
    Postgrad Med J; 2009 Mar; 85(1001):134-40. PubMed ID: 19351640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
    Hu X; Xuan Y
    Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic exploitation of necroptosis for cancer therapy.
    Fulda S
    Semin Cell Dev Biol; 2014 Nov; 35():51-6. PubMed ID: 25065969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
    Lorenzo HK; Susin SA
    Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis-modulating drugs for improved cancer therapy.
    Ocker M; Höpfner M
    Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apoptosis-reactivating agents for targeted anticancer therapy].
    Fil'chenkov AA
    Biomed Khim; 2013; 59(2):119-43. PubMed ID: 23789342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis.
    Gali-Muhtasib H; Hmadi R; Kareh M; Tohme R; Darwiche N
    Apoptosis; 2015 Dec; 20(12):1531-62. PubMed ID: 26362468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
    O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
    Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials.
    Andón FT; Fadeel B
    Acc Chem Res; 2013 Mar; 46(3):733-42. PubMed ID: 22720979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive luminescent transition-metal complexes for biomedical applications.
    Ma DL; He HZ; Leung KH; Chan DS; Leung CH
    Angew Chem Int Ed Engl; 2013 Jul; 52(30):7666-82. PubMed ID: 23765907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy as a mediator of chemotherapy-induced cell death in cancer.
    Notte A; Leclere L; Michiels C
    Biochem Pharmacol; 2011 Sep; 82(5):427-34. PubMed ID: 21704023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell death independent of caspases: a review.
    Bröker LE; Kruyt FA; Giaccone G
    Clin Cancer Res; 2005 May; 11(9):3155-62. PubMed ID: 15867207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.
    Kim R; Emi M; Tanabe K; Uchida Y; Arihiro K
    Eur J Surg Oncol; 2006 Apr; 32(3):269-77. PubMed ID: 16431074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death in the cellular differentiation of microbial eukaryotes.
    Ramsdale M
    Curr Opin Microbiol; 2012 Dec; 15(6):646-52. PubMed ID: 23083808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.